Praxis Precision Medicines Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,734.1% | 3,279.6% | 3,688.0% | 3,570.5% | 6,260.8% | 7,635.9% | 13,867.9% | 754.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,634.1% | -3,179.6% | -3,588.0% | -3,470.5% | -6,160.8% | -7,535.9% | -13,767.9% | -654.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,734.1% | 3,279.6% | 3,688.0% | 3,570.5% | 6,260.8% | 7,635.9% | 13,867.9% | 754.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,942.9% | 1,296.7% | 1,864.1% | 1,928.7% | 3,557.5% | 2,965.0% | 5,051.7% | 202.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,942.9% | 1,296.7% | 1,864.1% | 1,928.7% | 3,557.5% | 2,965.0% | 5,051.7% | 202.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,577.0% | -4,476.3% | -5,452.1% | -5,399.2% | -9,718.3% | -10,500.8% | -18,819.5% | -857.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15.5% | – | – | 20.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,483.9% | -4,393.3% | -5,263.2% | -5,219.0% | -9,177.0% | -9,153.2% | -17,188.7% | -786.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -93.1% | -2.1% | -23.3% | 144.7% | -26.0% | -30.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,483.9% | -4,393.3% | -5,263.2% | -5,219.0% | -9,177.0% | -9,153.2% | -17,188.7% | -786.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,468.4% | -4,379.8% | -5,240.0% | -5,176.9% | -9,151.0% | -9,123.2% | -17,158.3% | -785.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.